A61K 38/14
Peptides containing saccharide radicals
Official title: Peptides containing saccharide radicals; Derivatives thereof {, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin}
A61K38/14 (Peptides containing saccharide radicals) appears on 660 US grants and 1,260 published applications in this corpus.
Search patents in A61K- Granted patents
- 660
- Published applications
- 1,260
- Assignees
- 616
- Inventors
- 2,170
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 5 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 2 | 0 |
| 2001 | 5 | 3 |
| 2002 | 11 | 10 |
| 2003 | 8 | 27 |
| 2004 | 4 | 18 |
| 2005 | 11 | 26 |
| 2006 | 17 | 20 |
| 2007 | 6 | 20 |
| 2008 | 10 | 25 |
| 2009 | 11 | 24 |
| 2010 | 10 | 22 |
| 2011 | 6 | 30 |
| 2012 | 14 | 34 |
| 2013 | 21 | 37 |
| 2014 | 19 | 48 |
| 2015 | 28 | 72 |
| 2016 | 38 | 99 |
| 2017 | 48 | 95 |
| 2018 | 64 | 76 |
| 2019 | 46 | 78 |
| 2020 | 49 | 78 |
| 2021 | 38 | 88 |
| 2022 | 30 | 84 |
| 2023 | 44 | 70 |
| 2024 | 28 | 61 |
| 2025 | 40 | 60 |
| 2026 | 17 | 55 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Medication that protects the intestinal microbiota and their preparation methods and applications6 Oct 2026US 12,751,921 B2University of Science and Technology of China
- Imidazole-based synthetic lipidoids for in vivo mRNA delivery into immune cells29 Sep 2026US 12,747,214 B2Trustees of Tufts College
- Oral liposomal compositions22 Sep 2026US 12,741,009 B2
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Methods and compositions for delivery of a therapeutic agent18 Aug 2026US 12,708,674 B2
- Inverse agonists of rar related orphan receptors (rors)8 Oct 2026US 2026/0306484 A111949098 CANADA INC. (NUREDCO) c/o Jean I. TCHERVENKOV
- Water-soluble biomolecular glass microneedle and preparation method thereof1 Oct 2026US 2026/0294794 A1Institute of Process Engineering, Chinese Academy of Sciences
- Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns1 Oct 2026US 2026/0297191 A1ImmunoBrain Checkpoint, Inc.
- Aldoxime antibiotics and related methods24 Sep 2026US 2026/0283985 A1
- Compositions and methods for treating or preventing clostridium difficile infection, neutropenia, cardiovascular disease, asthma, and/or cancer24 Sep 2026US 2026/0284123 A1Vedanta Biosciences, Inc.
Most cited
By later US patents
- Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides1,595US 4,522,811 ASyntex (U.S.A.) Inc. · 1985
- Method for manufacturing a porous ceramic scaffold having an organic/inorganic hybrid coating layer containing a bioactive factor777US 8,734,831 B2Snu R&Db Foundation · 2014
- Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth243US 6,861,053 B1Cedars-Sinai Medical Center · 2005
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Incorporation of biological molecules into bioactive glasses154US 5,874,109 AThe Trustees of the University of Pennsylvania · 1999